Vertaling van "will be implemented under " (Nederlands → Frans) :

This merger, which will be implemented under the Swiss Merger Act, is in the interest of all stakeholders and will provide the needed clarity on Alcon’s future.
Cette fusion, qui sera réalisée conformément à la loi fédérale sur la fusion, est dans l'intérêt de toutes les parties prenantes en clarifiant l’avenir d’Alcon.

Under the terms of the CIA, which has a fixed term of five years, NPC will implement additional compliance-related measures.
Selon les termes du CIA, dont la période a été fixée à cinq ans, NPC mettra en place des mesures additionnelles de mise en conformité.

1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines
1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines

Finally, the implementation of the new structure of the FAMHP will have a considerable impact on the Veterinary Medicines unit, as the current powers/responsibilities relating to the PRE and POST pillars will be redistributed.
Finally, the implementation of the new structure of the FAMHP will have a considerable impact on the Veterinary Medicines unit, as the current powers/responsibilities relating to the PRE and POST pillars will be redistributed.

Under the guidance of two consultants and a Central Working Group, the “FAGG-AFMPS 2008” project started up in late June 2007 with the main goal of coming up with a design for the future organisation and implementing that design.
Under the guidance of two consultants and a Central Working Group, the “FAGG-AFMPS 2008” project started up in late June 2007 with the main goal of coming up with a design for the future organisation and implementing that design.

Opportunities for collaboration are now being explored, although any implementation will recognize the arm’s-length principle.
Les possibilités de collaboration sont en cours d'exploration, même si le principe de la pleine concurrence doit être respecté.

Following the merger under Swiss law, Alcon will become a new division that incorporates CIBA Vision and certain Novartis ophthalmic medicines.
A la suite de la fusion en droit suisse, Alcon deviendra une nouvelle division de Novartis qui intégrera CIBA Vision et certains médicaments ophtalmologiques de Novartis.

Novartis believes this merger, which is governed under the Swiss Merger Act, is in the interest of all stakeholders and will provide the needed clarity on Alcon’s future.
Novartis est convaincu que cette fusion, qui sera réalisée conformément à la loi fédérale suisse sur la fusion, est dans l’intérêt de toutes les parties prenantes en apportant la clarté nécessaire à l’avenir d’Alcon.

In addition to monthly reports containing financial information prepared under International Financial Reporting Standards (IFRS), senior management will receive a monthly analysis incorporating these core measures.
En plus des rapports mensuels contenant des informations financières préparées selon les normes IFRS (International Financial Reporting Standards), les cadres dirigeants recevront une analyse mensuelle intégrant ces mesures «core».

These skills will be crucial for implementing Novartis' strategy.
Ces compétences seront cruciales pour réaliser la stratégie de Novartis.